Cited by 179Fatty Acid Research and HealthLipoproteins and Cardiovascular HealthLipid metabolism and disorders

Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.

Open access
Kelley, Darshan S, Siegel, David, Vemuri, Madhuri, Mackey, Bruce E·2007·The American Journal of Clinical Nutrition

Abstract

Background The effects of docosahexaenoic acid (DHA) on the mean size and concentrations of VLDL, LDL, and HDL subclasses have not been previously studied.Objective We determined the effects of DHA supplementation on the concentrations of apoproteins; large, medium, and small VLDL, LDL, and HDL particles; and the mean diameters of these particles in fasting and postprandial plasma.Design Hypertriglyceridemic men aged 39-66 y (n = 34) participated in a double-blind, randomized, placebo-controlled parallel study. They received no supplements for the first 8 d and received either 7.5 g DHA oil/d (3 g DHA/d) or olive oil (placebo) for the last 90 d. Lipoprotein particle diameters and concentrations were measured by nuclear magnetic resonance spectroscopy.Results DHA supplementation for 45 d significantly (P < 0.05) decreased concentrations of fasting triacylglycerol (24%), large VLDL (92%), and intermediate-density lipoproteins (53%) and the mean diameter of VLDL particles (11.1 nm). It elevated concentrations of LDL cholesterol (12.6%), small VLDL particles (133%), and large LDL particles (120%) and the mean diameter of LDL particles (0.6 nm) in fasting plasma. Similar changes were observed for area under the curve for postprandial samples (0-6 h); however, the number of small dense LDL particles decreased significantly (21%), and the change in LDL cholesterol was not significant. Continued supplementation with DHA beyond 45 d caused no further changes; placebo treatment altered none of the responses tested.Conclusion DHA supplementation may improve cardiovascular health by lowering concentrations of triacylglycerols and small, dense LDL particles.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/86.2.324

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 50 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Calder PC. nҀ3 Fatty acids and cardiovascular disease: evidence ex- plained and mechanisms explored. Clin Sci (Lond) 2004;107:1-11.
  2. Sanders TA, Gleason K, Griffin B, Miller GJ. Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6nҀ3) and doco- sapentaenoic acid (22:5nҀ6) on cardiovascular risk factors in healthy men and women. Br J Nutr 2006;95:525-31.

Cited by

Sorted by citations

Authors
Kelley, D. S., Siegel, D., Vemuri, M., & Mackey, B. E.
Affiliations
Agricultural Research Service (US)
Corresponding author
Kelley, Darshan S
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2007-08
Volume
86
Issue
2
Pages
324-333
ISSN
0002-9165 (ISSN-L)
OpenAlex
W1937978193
Cited by
179
References
50
Citations by year
2026: 2 · 2025: 2 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 8 · 2019: 5 · 2018: 9 · 2017: 6 · 2016: 8 · 2015: 17 · 2014: 16 · 2013: 15 · 2012: 12
FWCI
13.61
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Agriculture (UL1 RR024146)
  • National Institutes of Health (RR024146)
  • Agricultural Research Service
  • National Center for Research Resources (RR-024146, UL1RR024146)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
docosahexaenoic acid, omega-3 supplementation, hypertriglyceridemia, lipoprotein particle size, VLDL particles, LDL cholesterol, HDL cholesterol, small dense LDL, postprandial lipemia, triglycerides, apolipoproteins, olive oil placebo, cardiovascular health
MeSH terms
Adult, Aged, Docosahexaenoic Acids, Double-Blind Method, Fasting, Humans, Lipids, Lipoproteins, Lipoproteins, HDL, Lipoproteins, LDL, Cholesterol, LDL, Lipoproteins, VLDL, Male, Middle Aged, Placebos, Triglycerides, Hypertriglyceridemia, Patient Selection, Postprandial Period, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review